Clinical use of an orally acting converting enzyme inhibitor: captopril.
- 1 July 1980
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 2 (4), 558-566
- https://doi.org/10.1161/01.hyp.2.4.558
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRILThe Lancet, 1979
- RATIONAL USE OF CAPTOPRILThe Lancet, 1979
- Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.Heart, 1978
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Hypertension in terminal renal failureKidney International, 1976
- Angiotensin II Vascular Receptors: Their Avidity in Relationship to Sodium Balance, the Autonomic Nervous System, and HypertensionJCI Insight, 1972
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971
- PLASMA RENIN ACTIVITY IN CHRONIC NEPHROPATHYActa Medica Scandinavica, 1970